<--- Back to Details
First PageDocument Content
Macular degeneration / Low vision / Visual impairment / Blindness / Macula of retina / Disability / Dementia / AMD Alliance International / Prevention of Blindness Society of Metropolitan Washington / Ophthalmology / Vision / Health
Date: 2013-05-01 22:51:38
Macular degeneration
Low vision
Visual impairment
Blindness
Macula of retina
Disability
Dementia
AMD Alliance International
Prevention of Blindness Society of Metropolitan Washington
Ophthalmology
Vision
Health

The Hon Julia Gillard MP Prime Minister PO Box 6022 House of Representatives Parliament House Canberra ACT 2600

Add to Reading List

Source URL: www.mdfoundation.com.au

Download Document from Source Website

File Size: 87,99 KB

Share Document on Facebook

Similar Documents

Strictly embargoed for 00.01hrs, Friday 20 November  New target for macular degeneration gets funding for clinical trials The Medical Research Council is to fund researchers at the UCL Institute of Ophthalmology and Moor

Strictly embargoed for 00.01hrs, Friday 20 November New target for macular degeneration gets funding for clinical trials The Medical Research Council is to fund researchers at the UCL Institute of Ophthalmology and Moor

DocID: 1tWX0 - View Document

November 25, 2015 Foundation for Biomedical Research and Innovation RIKEN Kobe City Medical Center General Hospital Termination of subject enrollment for the “Clinical study of autologous induced pluripotent stem cell-

November 25, 2015 Foundation for Biomedical Research and Innovation RIKEN Kobe City Medical Center General Hospital Termination of subject enrollment for the “Clinical study of autologous induced pluripotent stem cell-

DocID: 1rstZ - View Document

What is OCT and what can you do with OCT? Introduction For most people, the severe vision loss of visual acuity or blindness are the worst imaginable fate that often more feared than cancer or death. But for most patient

What is OCT and what can you do with OCT? Introduction For most people, the severe vision loss of visual acuity or blindness are the worst imaginable fate that often more feared than cancer or death. But for most patient

DocID: 1rmdW - View Document

October 9, 2015 (Initially issued in Japanese on October 2, 2015) Foundation for Biomedical Research and Innovation (FBRI) RIKEN Kobe City Medical Center General Hospital Update on first transplant recipient in the “Cl

October 9, 2015 (Initially issued in Japanese on October 2, 2015) Foundation for Biomedical Research and Innovation (FBRI) RIKEN Kobe City Medical Center General Hospital Update on first transplant recipient in the “Cl

DocID: 1rm8x - View Document

2016 Pathways to Cures: Clinical Translational Research Day at UCI ORAL PRESENTATIONS 4:00 pm – 5:00 pm Pacific Ballroom D Session moderated by Dr. Michael Stamos

2016 Pathways to Cures: Clinical Translational Research Day at UCI ORAL PRESENTATIONS 4:00 pm – 5:00 pm Pacific Ballroom D Session moderated by Dr. Michael Stamos

DocID: 1r4Al - View Document